Individualized and fine-tuned treatment
The medical company that has developed an innovative system for individualized dosing of tablets.
Sensidose AB is a pharmaceutical company that has developed a system for individualized dosing of tablets, a medical treatment using a dosing device pre-programmed for the patient. The system consists of tablets, containing low dose in each individual tablet. The correct dose is obtained by dosing a specific number of tablets. The tablets are dispensed using an electronic dispenser, programmed by the healthcare provider. The dispenser has a built-in alarm, delivers doses at the preset times and registers all doses delivered and also disease symptoms using rating scales that are easy to use. The company’s technology does not affect the course of the disease but treats the symptoms of the disease.
Sensidose will participate at the BioStock Investor Meeting on March 16. The presentation starts at 14:05. Follow the event online here: https://youtu.be/tv-ZDUn3zzI https://youtu.be/tv-ZDUn3zzI #Sensidose #BioStockSWE #investormeeting #LifeSciences
Sensidose signs an agreement with Desitin Arzneimittel GmbH for sales and marketing of Flexilev/Suades in Germany
Sensidose AB (the "Company") has entered into a service agreement with Desitin Arzneimittel GmbH ("Desitin") for the sales and marketing of Flexilev (under the trade name Suades) in Germany. Sensidose and Desitin will share the revenue from the sales. The launch is...
Sensidose is awarded funding from Vinnova (Sweden´s Innovation Agency) to develop a method for objective registration and treatment of opiate-requiring pain conditions
Sensidose receives SEK 1.22 million in grants from Vinnova for industrial research within the call "Innovation projects in companies". The funding aims to support the company's development of measuring physiological reactions to pain to enable improved pain relief and...
MyFID is a programmable dosing device for tablets. By combining the possibilities of a modern technology and tablets with a smaller amount of active ingredients, a fine-tuned dosing can be achieved. By choosing a number of tablets a specific, individualized dose can be arrived.
MyFID is pre-programmed to deliver a certain amount of medicine at a certain time. The physician decides which dose a patient should use and when it should be taken. However in order for the device not to rule the user’s life, care has been taken to ensure that the user choose which functions of the device that should be active.
MyFID has unique registration capabilities. It registers the amount and time a dose is delivered. MyFID will ask and record reasons why a dose is taken. It also records disease symptoms using easy to use scales that allows for the patient and the doctor to follow treatment effects, to get a continuous picture of how the disease evolves and fluctuates with time.
All information recorded is available for both the user and the physician, and can be retrieved using an inbuilt standardized treatment report. MyFID therefore gives the physician and the patient a more precise and correct background for further treatment decisions.
Flexilev is prescribed to you by a doctor who knows how to treat Parkinson’s disease. Before you start the treatment, it is good to know a little about the treatment that takes place with the help of a dispensing machine. It is important to take Flexilev at every prescribed dose at the doctor’s recommendation. It increases the chance of regular symptom relief.
Flexilev is a prescription drug in the form of small “micro-tablets” that are taken with the help of a dose dispenser, MyFID. The dose dispenser, which can be programmed by your doctor or nurse, delivers a certain number of tablets at each dosing time.
Org. Nr. 556550-3074
Vetenskapsvägen 10 191 38 Sollentuna
Tel : 010 – 70 77 380
191 38 Sollentuna, Sverige